Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 10. 16.
 ÀÌÁ¾Àå±â ½ÉÇ÷°ü°èÀÌÁ¾À̽ݳ¹ß
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2010.09.08. 08:59:45   Á¶È¸: 4257
2010³â 9¿ù 3ÀÏ¿¡¼­ 4ÀϱîÁö °æ±âµµ ¾çÆò±º ¼­Á¾¸é ¹®È£¸® 573    ÇÏÀ̵ð Ææ¼Ç¿¡¼­ 2010³â Ãß°è ¿öÅ©»ð ¹× ½ÉÀå¿Ü°úÇÐ ±³°ú¼­ ¸ðÀÓÀ» °³ÃÖÇÏ¿´´Ù. ¹ßÇ¥³»¿ëÀº ¾Æ·¡¿Í °°¾Ò´Ù.

Introduction                                                                   ±è¿ëÁø

Mechanical effects of detergents & enzyme treatment            ±è¼öÇÑ

Double crosslinking & space filler, cell seeding                      À±ÀºÁ¤

Effects & use of alpha-galactosidase in xenograft                  ÃÖ¼±¿µ

Xenoreactive antibodies in bioprosthetic valve replacement     ¹Úõ¼ö
Results of recent studies of xenograft on GT-KO mice            ÀÌ  ö

Results of anticalcification study of xenograft on rabbit          ÀÓÈ«±¹

Further studies on GT-KO mice implantation                         ÀÓÈ«±¹

Anticalcification on rabbit experiments & expectations           ÀÌ¿µ¿Á
Anticalcification on rat muscular implatation model               ¹Îº´ÁÖ
Decellulization experiments, past, present, future                  ¼º½ÃÂù

Progress of stented valve & valved conduit                          È«°­¼±

¸¹Àº ¿¬±¸¿øµéÀÌ Âü¼®ÇÏ¿© ÁøÁöÇÏ°í Áñ°Å¿î ÅäÀǸ¦ °¡Á³´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 10. 16.  Àüü±Û: 215  ¹æ¹®¼ö: 1060873
111 Áß±¹ ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼úÁö¿ø °ü¸®ÀÚ2010.11.29.4057
110 Áß±¹ ±æ¸²¼º ¿¬º¯ ´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼úÁö¿ø °ü¸®ÀÚ2010.11.21.6464
109 2010 ³âµµ advisory symposium °ü¸®ÀÚ2010.11.16.4219
108 Á¦42Â÷ ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Ãß°èÇмú´ëȸ °ü¸®ÀÚ2010.11.10.4237
107 Á¦ 63Â÷ ÀϺ»ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2010.10.27.4225
106 ÀÌÁ¾Àå±â ½ÉÇ÷°ü°èÀÌÁ¾À̽ݳ¹ß °ü¸®ÀÚ2010.09.08.4257
105 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2010.08.21.4517
104 ¼­¿ï´ëÇб³º´¿øÀå ǥâÆÐ ¼ö¿© °ü¸®ÀÚ2010.08.21.4198
103 Á¦ 3Â÷ ¾Æ½Ã¾Æ-ÅÂÆò¾ç ¼Ò¾Æ½ÉÀåÇÐȸ Çмú´ëȸ °ü¸®ÀÚ2010.07.09.4344
102 Áß±¹ Èæ·æ°­¼º ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2010.06.20.4382
RELOAD WRITE
 1 ¢¸ 11 [12] [13] [14] [15] [16] [17] [18] [19] [20]  ¢º 22